Onkos Surgical received FDA 510(k) clearance to market the ELEOS™ Limb Salvage System to treat bone loss due to cancer, trauma or previous surgical procedures. Full launch is slated for 1Q17.
Other companies with limb salvage systems include Stanmore Implants (acquired by Stryker), Wright Medical and Zimmer Biomet.
Onkos Surgical received FDA 510(k) clearance to market the ELEOS™ Limb Salvage System to treat bone loss due to cancer, trauma or previous surgical procedures. Full launch is slated for 1Q17.
Other companies with limb salvage systems include Stanmore Implants (acquired by...
Onkos Surgical received FDA 510(k) clearance to market the ELEOS™ Limb Salvage System to treat bone loss due to cancer, trauma or previous surgical procedures. Full launch is slated for 1Q17.
Other companies with limb salvage systems include Stanmore Implants (acquired by Stryker), Wright Medical and Zimmer Biomet.
Copy to clipboard 
